SUPNdate,SUPNnews,SUPNsource11/21/20,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN",PMZ11/19/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Piper Sandler Health Care Conference - Pre-recorded for 23-November-2020",FCSTEV11/19/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Investor Meeting for 3-December-2020",FCSTEV11/18/20,Supernus to Participate in Annual Piper Sandler Healthcare Conference,PMZ11/18/20,"Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of Investors",BW11/12/20,DJ Press Release: Supernus to Present at Two November Investor Conferences,DJGM11/12/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies Healthcare Conference for 17-November-2020 1:45 PM ET",FCSTEV11/12/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Stifel Healthcare Conference for 16-November-2020 9:20 AM ET",FCSTEV11/11/20,Supernus to Present at Two November Investor Conferences,PMZ11/09/20,DJ Press Release: Supernus Provides Regulatory Updates for SPN-812 and SPN-830,DJGM11/09/20,Supernus Provides Regulatory Updates for SPN-812 and SPN-830,PMZ11/04/20,"Supernus Pharmaceuticals, Inc. to Host Earnings Call",NEWS_ACW11/03/20,DJ Press Release: Supernus Announces Third Quarter -2-,DJGM11/03/20,DJ Press Release: Supernus Announces Third Quarter 2020 Financial Results,DJGM11/03/20,Supernus Announces Third Quarter 2020 Financial Results,PMZ10/27/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2020 Earnings Call for 4-November-2020 9:00 AM ET",FCSTEV10/27/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2020 Earnings Release for 3-November-2020 5:00 PM ET",FCSTEV10/27/20,DJ Press Release: Supernus to Host Third Quarter 2020 Financial Results Conference Call,DJGM10/27/20,Supernus to Host Third Quarter 2020 Financial Results Conference Call,PMZ10/05/20,Supernus Pharmaceuticals Appoints James Kelly as Chief Financial Officer,PMZ10/05/20,DJ Press Release: Supernus Pharmaceuticals Appoints James Kelly as Chief Financial Officer,DJGM09/14/20,Supernus Submits NDA for SPN-830 for Continuous Treatment of ON-OFF Episodes in Adults with Parkinson's Disease Who Have Failed Two Treatments,PMZ09/14/20,DJ Press Release: Supernus Submits NDA for SPN-830 for Continuous Treatment of ON-OFF Episodes in Adults with Parkinson's Disease Who Have Failed Two Treatments,DJGM09/10/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Morgan Stanley Global Healthcare Conference for 16-September-2020 2:00 PM ET",FCSTEV09/09/20,DJ Press Release: Supernus to Present at the Morgan Stanley 18th Annual Global Healthcare Conference,DJGM09/09/20,Supernus to Present at the Morgan Stanley 18th Annual Global Healthcare Conference,PMZ09/03/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Wells Fargo Global Healthcare Conference for 9-September-2020 9:20 AM ET",FCSTEV09/02/20,DJ Press Release: Supernus to Present at the Wells Fargo Virtual Health Care Conference,DJGM09/02/20,Supernus to Present at the Wells Fargo Virtual Health Care Conference,PMZ08/18/20,Supernus Announces Second Quarter 2020 Financial Results,PMZ08/18/20,DJ Press Release: Supernus Announces Second Quarter -2-,DJGM08/18/20,DJ Press Release: Supernus Announces Second Quarter 2020 Financial Results,DJGM08/11/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2020 Earnings Call for 19-August-2020 9:00 AM ET",FCSTEV08/11/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2020 Earnings Release for 18-August-2020 5:00 PM ET",FCSTEV08/11/20,Supernus Announces Preliminary Second Quarter 2020 Revenue,PMZ08/11/20,DJ Press Release: Supernus Announces Preliminary Second Quarter 2020 Revenue,DJGM06/26/20,Supernus Sues Apotex for Infringement of Oxtellar XR¨ Patents,PMZ06/09/20,Supernus Completes Acquisition of CNS Portfolio from US WorldMeds,PMZ06/09/20,DJ Press Release: Supernus Completes Acquisition of CNS Portfolio from US WorldMeds,DJGM05/27/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies Virtual Healthcare Conference for 2-June-2020 4:00 PM ET",FCSTEV05/27/20,DJ Press Release: Supernus to Present at the Jefferies Virtual Health Care Conference,DJGM05/27/20,Supernus to Present at the Jefferies Virtual Health Care Conference,PMZ05/15/20,Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR¨,PMZ05/15/20,DJ Press Release: Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR(R),DJGM05/05/20,DJ Press Release: Supernus Announces First Quarter -2-,DJGM05/05/20,DJ Press Release: Supernus Announces First Quarter 2020 Financial Results,DJGM05/05/20,Supernus Announces First Quarter 2020 Financial Results,PMZ04/28/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Acquisition of CNS portfolio of US WorldMeds by Supernus Pharmaceuticals, Inc. Call for 29-April-2020 8:30 AM ET",FCSTEV04/28/20,DJ Press Release: Supernus to Acquire CNS Portfolio -2-,DJGM04/28/20,DJ Press Release: Supernus to Acquire CNS Portfolio from US WorldMeds,DJGM04/28/20,Supernus to Acquire CNS Portfolio from US WorldMeds,PMZ04/27/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2020 Earnings Call for 6-May-2020 9:00 AM ET",FCSTEV04/27/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2020 Earnings Release for 5-May-2020 6:46 PM ET",FCSTEV04/27/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Annual General Meeting for 15-June-2020",FCSTEV04/24/20,DJ Press Release: Supernus to Host First Quarter Results Earnings Conference Call,DJGM04/24/20,Supernus to Host First Quarter Results Earnings Conference Call,PMZ04/21/20,Supernus and Navitor Announce Development and Option Agreement for Orally Active mTORC1 Activator NV-5138,PMZ04/21/20,DJ Press Release: Supernus and Navitor Announce -2-,DJGM04/21/20,DJ Press Release: Supernus and Navitor Announce Development and Option Agreement for Orally Active mTORC1 Activator NV-5138,DJGM03/30/20,Supernus Provides Business Update,PMZ03/30/20,DJ Press Release: Supernus Provides Business Update,DJGM02/26/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Cowen Health Care Conference for 2-March-2020 4:10 PM ET",FCSTEV02/26/20,Supernus to Present at the 2020 Cowen Health Care Conference,PMZ02/26/20,DJ Press Release: Supernus to Present at the 2020 Cowen Health Care Conference,DJGM02/25/20,Supernus Announces Fourth Quarter and Full Year 2019 Financial Results,PMZ02/25/20,DJ Press Release: Supernus Announces Fourth Quarter -2-,DJGM02/25/20,DJ Press Release: Supernus Announces Fourth Quarter and Full Year 2019 Financial Results,DJGM02/11/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2019 Earnings Release for 25-February-2020 5:00 PM ET",FCSTEV02/11/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2019 Earnings Call for 26-February-2020 9:00 AM ET",FCSTEV02/11/20,DJ Press Release: Supernus to Host Fourth Quarter and Full Year 2019 Results Earnings Conference Call,DJGM02/11/20,Supernus to Host Fourth Quarter and Full Year 2019 Results Earnings Conference Call,PMZ01/21/20,Supernus Announces FDA Acceptance for Review of New Drug Application for SPN-812 for the Treatment of ADHD,PMZ01/21/20,DJ Press Release: Supernus Announces FDA Acceptance for Review of New Drug Application for SPN-812 for the Treatment of ADHD,DJGM01/08/20,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules JP Morgan Health Care Conference for 15-January-2020 1:30 PM ET",FCSTEV01/08/20,DJ Press Release: Supernus to Present at the 2020 J.P. Morgan Healthcare Conference,DJGM01/08/20,Supernus to Present at the 2020 J.P. Morgan Healthcare Conference,PMZ12/09/19,Supernus Provides Update on Results from Phase III Study (P301) of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients,PMZ12/09/19,DJ Press Release: Supernus Provides Update on Results from Phase III Study (P301) of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients,DJGM11/12/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies London Health Care Conference for 21-November-2019 9:40 AM ET",FCSTEV11/12/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Stifel Health Care Conference for 19-November-2019 1:50 PM ET",FCSTEV11/12/19,Supernus to Present at Two November Healthcare Conferences,PMZ11/11/19,DJ Press Release: Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD,DJGM11/11/19,Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD,PMZ11/05/19,Supernus Announces Third Quarter 2019 Financial Results and Topline Data fromÊPhase III Study of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients,PMZ11/05/19,DJ Press Release: Supernus Announces Third Quarter -2-,DJGM11/05/19,DJ Press Release: Supernus Announces Third Quarter 2019 Financial Results and Topline Data from Phase III Study of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients,DJGM11/05/19,DJ Press Release: Supernus Announces Third Quarter -3-,DJGM10/29/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2019 Earnings Release for 5-November-2019 4:55 PM ET",FCSTEV10/29/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2019 Earnings Call for 6-November-2019 9:00 AM ET",FCSTEV10/24/19,DJ Press Release: Supernus to Host Third Quarter 2019 Earnings Conference Call,DJGM10/24/19,Supernus to Host Third Quarter 2019 Earnings Conference Call,PMZ09/25/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Cantor Global Health Care Conference for 3-October-2019 5:20 PM ET",FCSTEV09/25/19,Supernus to Present at the 2019 Cantor GlobalÊHealthcare Conference,PMZ08/26/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Morgan Stanley Global Health Care Conference for 11-September-2019 11:05 AM ET",FCSTEV08/26/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Wells Fargo Health Care Conference for 5-September-2019 1:20 PM ET",FCSTEV08/26/19,Supernus to Present at Two SeptemberÊHealthcare Conferences,PMZ08/06/19,Supernus Announces Second Quarter 2019 Financial Results,PMZ07/23/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2019 Earnings Call for 7-August-2019 9:00 AM ET",FCSTEV07/23/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2019 Earnings Release for 6-August-2019 4:41 PM ET",FCSTEV07/23/19,Supernus to Host Second Quarter 2019 Earnings Conference Call,PMZ05/29/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies Healthcare Conference for 5-June-2019 2:00 PM ET",FCSTEV05/29/19,Supernus to Present at the Jefferies 2019 Global Healthcare Conference,PMZ05/07/19,Supernus Announces First Quarter 2019 Financial Results,PMZ05/01/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Annual General Meeting for 11-June-2019 10:00 AM ET",FCSTEV04/24/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2019 Earnings Call for 8-May-2019 9:00 AM ET",FCSTEV04/24/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2019 Earnings Release for 7-May-2019 5:09 PM ET",FCSTEV04/24/19,Supernus to Host First Quarter 2019 Earnings Conference Call,PMZ04/01/19,"Supernus Announces Webcast of Investor Day on April 16, 2019",PMZ03/28/19,Supernus Announces P304 Phase III Data Confirming Positive Results from Previous Three Phase III Studies on SPN-812 in ADHD,PMZ03/27/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules SPN-812 Phase III Study Results Call for 28-March-2019 9:00 AM ET",FCSTEV03/27/19,Supernus Hosts Conference Call to Present Topline Results of Final Phase III Study for SPN-812 in Adolescents with ADHD,PMZ03/13/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Cowen & Co. Health Care Conference for 13-March-2019 9:20 AM ET",FCSTEV03/07/19,"Recent Analysis Shows Golar LNG, AG Mortgage Investment Trust, AmerisourceBergen, Caesarstone, Dycom Industries, and Supernus Pharmaceuticals Market Influences - Renewed Outlook, Key Drivers of Growth",PMZ03/06/19,Supernus to Present at the 2019 Cowen Health Care Conference,PMZ02/26/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Investor Day for 16-April-2019 8:30 AM ET",FCSTEV02/26/19,Supernus Announces Record Full Year 2018 Financial Results,PMZ02/12/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2018 Earnings Call for 27-February-2019 9:00 AM ET",FCSTEV02/12/19,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2018 Earnings Release for 26-February-2019 5:00 PM ET",FCSTEV02/12/19,Supernus to Host Fourth Quarter and Full Year 2018 Earnings Conference Call,PMZ12/24/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules J.P. Morgan Healthcare Conference for 9-January-2019 1:30 PM ET",FCSTEV12/21/18,Supernus to Present at the 2019 J.P. Morgan Healthcare Conference,PMZ12/20/18,Supernus Announces Positive Results from Phase III Study For SPN-812 in Adolescents with ADHD,PMZ12/14/18,Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR¨ Label to Include Monotherapy,PMZ12/06/18,Supernus Announces Positive Results from Two Phase III Studies For SPN-812 in Children with ADHD,PMZ12/05/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules SPN-812 Phase III Topline Study Results Call for 6-December-2018 9:00 AM ET",FCSTEV12/05/18,Supernus Schedules Conference Call to Present Topline Results of Two Phase III Studies for SPN-812 in Children with ADHD,PMZ11/07/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies Health Care Conference for 15-November-2018 9:40 AM ET",FCSTEV11/07/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Piper Jaffray Health Care Conference for 27-November-2018 12:00 PM ET",FCSTEV11/07/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Stifel Health Care Conference for 13-November-2018 3:30 PM ET",FCSTEV11/07/18,Supernus to Present at Three November Healthcare Conferences,PMZ11/06/18,Supernus Announces Third Quarter 2018 Financial Results and Record Quarterly Revenue,PMZ10/26/18,"Recent Analysis Shows Supernus Pharmaceuticals, GDS HOLDINGS, Golden Ocean Group, Golar LNG, Endo International plc, and 51job Market Influences - Renewed Outlook, Key Drivers of Growth",PMZ10/24/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2018 Earnings Release for 6-November-2018 5:00 PM ET",FCSTEV10/24/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2018 Earnings Call for 7-November-2018 9:00 AM ET",FCSTEV10/24/18,Supernus to Host Third Quarter 2018 Earnings Conference Call,PMZ09/27/18,"New Research Coverage Highlights Randgold Resources, California Water Service Group Holding, B&G Foods, Hawaiian, Bank of Nova Scotia, and Supernus Pharmaceuticals - Consolidated Revenues, Company Growth, and Expectations for 2018",PMZ09/20/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Cantor Global Healthcare Conference for 3-October-2018 8:35 AM ET",FCSTEV09/20/18,Supernus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference,PMZ09/13/18,Supernus to Acquire Biscayne Neurotherapeutics,PMZ09/06/18,Supernus Wins Appeal on Oxtellar XR¨ against TWi,PMZ08/29/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Wells Fargo Health Care Conference for 5-September-2018 11:25 AM ET",FCSTEV08/29/18,Supernus to Present at September 2018 Wells Fargo Healthcare Conference,PMZ08/07/18,Supernus Announces Second Quarter 2018 Financial Results and  Record Quarterly Revenue,PMZ07/25/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2018 Earnings Call for 8-August-2018 9:00 AM ET",FCSTEV07/25/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2018 Earnings Release for 7-August-2018 5:00 PM ET",FCSTEV07/25/18,Supernus to Host Second Quarter 2018 Earnings Conference Call,PMZ06/27/18,"Dr. Carrolee Barlow, M.D., Ph.D., Joins Supernus'ÊBoard of Directors",PMZ06/01/18,"Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders",PRN05/30/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies Global Healthcare Conference for 5-June-2018 11:00 AM ET",FCSTEV05/30/18,Supernus to Present at the 2018 Jefferies Healthcare Conference,PMZ05/08/18,Supernus Announces First Quarter 2018 Financial Results and  Record Quarterly Revenue,PMZ05/03/18,"Technical Perspectives on Generic Drugs Stocks -- Allergan, Catalyst Pharma, Flexion Therapeutics, and Supernus Pharma",PRN05/02/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Annual General Meeting for 12-June-2018 10:00 AM ET",FCSTEV04/24/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2018 Earnings Release for 8-May-2018 5:00 PM ET",FCSTEV04/24/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2018 Earnings Call for 9-May-2018 9:00 AM ET",FCSTEV04/24/18,Supernus to Host First Quarter 2018 Earnings Conference Call,PMZ03/06/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Cowen & Co. Health Care Conference for 13-March-2018 10:00 AM ET",FCSTEV03/06/18,Supernus to Present at the 2018 Cowen Health Care Conference,PMZ02/28/18,"Supernus Pharmaceuticals, Inc. to Host Earnings Call",NEWS_ACW02/27/18,"Supernus Announces Record Full Year 2017 Financial Results, Exceeding Operating Earnings Guidance",PMZ02/12/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2017 Earnings Call for 28-February-2018 9:00 AM ET",FCSTEV02/12/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2017 Earnings Release for 27-February-2018 5:00 PM ET",FCSTEV02/12/18,Supernus to Host Fourth Quarter and Full Year 2017 Earnings Conference Call,PMZ01/12/18,Supernus Mourns the Loss of Board Member William Nuerge,PMZ01/02/18,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules J.P. Morgan Health Care Conference for 10-January-2018 3:00 PM ET",FCSTEV01/02/18,Supernus to Present at the 2018 J.P. Morgan Healthcare Conference,PMZ11/08/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies London Health Care Conference for 16-November-2017 11:40 AM ET",FCSTEV11/08/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Stifel Nicolaus Health Care Conference for 14-November-2017 11:45 AM ET",FCSTEV11/08/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Piper Jaffray Health Care Conference for 29-November-2017 8:00 AM ET",FCSTEV11/08/17,Supernus to Present at Three November Healthcare Conferences,PMZ11/07/17,"Supernus Pharmaceuticals, Inc. to Host Earnings Call",NEWS_ACW11/06/17,Supernus Announces Third Quarter 2017 Financial Results,PMZ10/24/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2017 Earnings Release for 6-November-2017 5:00 PM ET",FCSTEV10/24/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2017 Earnings Call for 7-November-2017 9:00 AM ET",FCSTEV10/24/17,Supernus to Host Third Quarter 2017 Earnings Conference Call,PMZ10/20/17,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Supernus Pharmaceuticals, Inc.",BW09/18/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules SPN-810 Phase III Clinical Trials Results Call for 18-September-2017 5:00 PM ET",FCSTEV09/18/17,Supernus Provides Update on SPN-810 Phase III Clinical Trials,PMZ09/05/17,"Technical Snapshots for These Generic Drugs Stocks -- Catalyst Pharma, Flexion Therapeutics, Supernus Pharma, and Lannett",PRN08/15/17,Supernus Defeats Second Generic Challenger to Oxtellar XR¨,PMZ08/03/17,"Investor Network: Supernus Pharmaceuticals, Inc. to Host Earnings Call",NEWS_ACW08/02/17,Supernus Announces Record Second Quarter 2017 Financial Results,PMZ07/19/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2017 Earnings Release for 2-August-2017 5:00 PM ET",FCSTEV07/19/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2017 Earnings Call for 3-August-2017 9:00 AM ET",FCSTEV07/19/17,Supernus to Host Second Quarter 2017 Earnings Conference Call,PMZ06/21/17,Supernus Announces that its Partner Shire Receives FDA Approval for Mydayisª for ADHD,PMZ06/12/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Annual General Meeting for 13-June-2017",FCSTEV06/05/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies Global Health Care Conference for 7-June-2017 1:30 PM ET",FCSTEV06/01/17,Supernus to Present at Jefferies Healthcare Conference,PMZ05/10/17,"Investor Network: Supernus Pharmaceuticals, Inc. to Host Earnings Call",NEWS_ACW05/09/17,Supernus Announces First Quarter 2017 Financial Results,PMZ04/26/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2017 Earnings Release for 9-May-2017 5:00 PM ET",FCSTEV04/26/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2017 Earnings Call for 10-May-2017 9:00 AM ET",FCSTEV04/26/17,Supernus to Host First Quarter 2017 Earnings Conference Call,PMZ04/05/17,Supernus Receives Final FDA Approval for Trokendi XR¨ for Migraine Prophylaxis in Adults and Adolescents,PMZ03/07/17,Supernus Announces Settlement with Actavis on Trokendi XR¨ Patent Litigation,PMZ03/07/17,Zydus announces settlement with Supernus on Trokendi XR¨ (topiramate) extended-release capsules,NEWS_CR03/06/17,Supernus Announces Settlement with Zydus on Trokendi XR¨ Patent Litigation,PMZ02/28/17,Supernus Announces Record Fourth Quarter and Full Year 2016 Financial Results,PMZ02/27/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Cowen and Company Global Health Care Conference for 8-March-2017 10:40 AM ET",FCSTEV02/27/17,Supernus to Present at Cowen Health Care Conference in March,PMZ02/13/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2016 Earnings Release for 28-February-2017 5:00 PM ET",FCSTEV02/13/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2016 Earnings Call for 1-March-2017 9:00 AM ET",FCSTEV02/13/17,Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call,PMZ02/08/17,Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR¨,PMZ01/30/17,Supernus Announces Issuance of Seventh U.S. Patent  Protecting Trokendi XR¨,PMZ01/23/17,Supernus Files Form 10-Q for Third Quarter 2016 and Is Now Current with All Financial Filings,PMZ01/22/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2016 Earnings Release for 23-January-2017",FCSTEV01/03/17,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules J.P. Morgan Health Care Conference for 10-January-2017 7:00 PM ET",FCSTEV01/03/17,Supernus to Present at the 2017 J.P. Morgan Healthcare Conference,PMZ12/12/16,Supernus Wins Appeal Case on Oxtellar XR¨,PMZ11/17/16,Supernus Receives Nasdaq Non-Compliance Notice,PMZ11/14/16,Supernus Provides Business Update,PMZ11/13/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2016 Sales and Revenue Release for 14-November-2016",FCSTEV11/11/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2016 Sales and Revenue Call for 14-November-2016 9:00 AM ET",FCSTEV11/11/16,Supernus to Host a Business Update Call,PMZ11/07/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Stifel Healthcare Conference for 15-November-2016 10:15 AM ET",FCSTEV11/07/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies London Health Care Conference for 17-November-2016 10:20 AM ET",FCSTEV11/07/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Piper Jaffray Health Care Conference for 29-November-2016 9:00 PM ET",FCSTEV11/07/16,Supernus to Present at Three November Healthcare Conferences,PMZ10/12/16,Blog Coverage Supernus Reports Positive Results from Phase IIb Clinical Trial for SPN-812,NEWS_ACW10/11/16,Supernus Announces Positive Results from Phase IIb Clinical Trial For SPN-812 in Children with ADHD,PMZ10/10/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules SPN-812 Phase IIb Trial Results Call for 11-October-2016 9:00 AM ET",FCSTEV10/10/16,Supernus Schedules Conference Call to Present Results of  Phase IIb Clinical Trial of SPN-812 in Children with ADHD,PMZ09/19/16,"Learn how to target a 20% return on Netflix, or get option-trade ideas on Supernus Pharmaceuticals, Avis, Intel and UnitedHealth or any stock you choose",PRN08/19/16,Supernus Receives FDA Tentative Approval for Expanded Label of Trokendi XR¨ to Include Migraine Prophylaxis in Adults,PMZ08/12/16,"Supernus Announces Resignation of Dr. James Barrett from Board of Directors; Charles W. Newhall, III Elected Chairman",PMZ08/02/16,Supernus Announces Second Quarter 2016 Financial Results,PMZ07/20/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2016 Earnings Call for 3-August-2016 9:00 AM ET",FCSTEV07/20/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2016 Earnings Release for 2-August-2016 5:00 PM ET",FCSTEV07/20/16,Supernus to Host Second Quarter 2016 Earnings Conference Call,PMZ06/28/16,"Drugs - Generic Stocks Technical Snapshot - Sophiris Bio, Neurocrine Biosciences, Lannett, and Supernus Pharma",PRN06/22/16,Supernus Announces Issuance of Seventh U.S. Patent Protecting Oxtellar XR¨,PMZ06/16/16,Supernus Provides Update on Trokendi XR¨ Migraine sNDA and Reiterates Guidance,PMZ06/02/16,Supernus Announces Issuance of Sixth U.S. Patent Protecting Oxtellar XR¨,PMZ05/24/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies Health Care Conference for 7-June-2016 1:30 PM ET",FCSTEV05/24/16,Supernus to Present at June Jefferies Healthcare Conference,PMZ05/10/16,Supernus Enters Into Partial Settlement Agreement with Actavis on Oxtellar XR¨,PMZ05/03/16,Supernus Announces First Quarter 2016 Financial Results,PMZ04/22/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Annual General Meeting for 19-May-2016",FCSTEV04/19/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2016 Earnings Call for 4-May-2016 9:00 AM ET",FCSTEV04/19/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2016 Earnings Release for 3-May-2016 After Market Hours ET",FCSTEV04/19/16,Supernus to Host First Quarter 2016 Earnings Conference Call,PMZ04/01/16,"Supernus Pharmaceuticals Selects DSG, Inc. for EDC and IWRS in Phase 3 Clinical Studies on Impulsive Aggression in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder (ADHD)",BW03/02/16,Supernus Announces Record Fourth Quarter and Full Year 2015 Financial Results,PMZ02/25/16,Supernus to Present at March Cowen Health Care Conference,PMZ02/18/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2015 Earnings Call for 3-March-2016 9:00 AM ET",FCSTEV02/18/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2015 Earnings Release for 2-March-2016 After Market Hours ET",FCSTEV02/18/16,Supernus to Host Fourth Quarter and Full Year 2015 Earnings Conference Call,PMZ02/17/16,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Cowen and Company Health Care Conference for 7-March-2016 2:40 PM ET",FCSTEV02/09/16,"Covered Call Alerts For Starbucks, GW Pharmaceuticals, Supernus Pharmaceuticals, CSX and SunEdison Released By InvestorsObserver",PRN02/08/16,Supernus Prevails in Oxtellar XR¨ ANDA Litigation,PMZ12/04/15,Supernus Announces Distribution of Common Stock by NEA,PMZ12/02/15,Supernus to Attend Guggenheim Securities Boston Healthcare Conference,PMZ11/12/15,Supernus Announces Distribution of Common Stock by NEA,PMZ11/09/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Stifel Health Care Conference for 17-November-2015 4:30 PM ET",FCSTTS11/09/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Piper Jaffray Health Care Conference for 1-December-2015 10:30 AM ET",FCSTEV11/09/15,Supernus to Present at Two Investor Conferences,PMZ11/03/15,Supernus Announces Third Quarter 2015 Financial Results and Raises 2015 Guidance,PMZ10/22/15,Supernus Announces FDA Acceptance of sNDA to Add Migraine to Trokendi XR(R) Label,PMZ10/20/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2015 Earnings Call for 4-November-2015 9:00 AM ET",FCSTTS10/20/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2015 Earnings Release for 3-November-2015 5:00 PM ET",FCSTEV10/20/15,Supernus to Host Third Quarter 2015 Earnings Conference Call,PMZ10/15/15,Supernus Announces Settlement With Par on Trokendi XR(R) Patent Litigation,PMZ09/29/15,"Drugs - Generic Equities at a Glance -- Mylan, Zoetis, Ironwood Pharma, Akorn, and Supernus Pharma",PRN09/02/15,Supernus Announces Issuance of Fifth U.S. Patent Protecting Oxtellar XR(R),PMZ08/27/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules FBR Health Care Conference for 9-September-2015",FCSTTS08/27/15,Supernus to Attend FBR Healthcare Conference on September 9th,PMZ08/05/15,"Drugs - Generic Equities Coverage -- Oculus Innovative Sciences, Medicines, Supernus Pharma, Sophiris Bio, and Rigel Pharma",PRN08/04/15,Supernus Announces Second Quarter 2015 Financial Results,PMZ07/20/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2015 Earnings Release for 4-August-2015 After Market Hours ET",FCSTEV07/20/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2015 Earnings Call for 5-August-2015 9:00 AM ET",FCSTEV07/20/15,Supernus to Host Second Quarter 2015 Earnings Conference Call,PMZ06/17/15,Supernus Corrects Earlier Statement Regarding Distribution of Common Stock by NEA,PMZ06/17/15,Supernus Announces Distribution of Common Stock by NEA,PMZ06/08/15,"Supernus Announces Webcast of Investor Day on June 17, 2015",PMZ06/04/15,Manhattan Associates Set to Join the S&P MidCap 400; Supernus Pharmaceuticals to be Added to the S&P SmallCap 600,PRN05/19/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies Global Healthcare Conference for 2-June-2015 2:00 PM ET",FCSTTS05/19/15,Supernus to Present at June Jefferies Healthcare Conference,PMZ05/05/15,Supernus Announces First Quarter 2015 Financial Results,PMZ04/21/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2015 Earnings Call for 6-May-2015 9:00 AM ET",FCSTTS04/21/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2015 Earnings Release for 5-May-2015 After Market Hours ET",FCSTEV04/21/15,Supernus to Host First Quarter 2015 Earnings Conference Call,PMZ04/02/15,Supernus Announces Issuance of Sixth U.S. Patent Protecting Trokendi XR(R),PMZ04/01/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Annual General Meeting for 21-May-2015",FCSTTS03/23/15,"Georges Gemayel, Ph.D., Joins Supernus Board of Directors",PMZ03/10/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Investor Day for 17-June-2015 8:30 AM ET",FCSTTS03/10/15,Supernus Announces Fourth Quarter and Full Year 2014 Results,PMZ02/18/15,Supernus to Present at March Cowen Conference,PMZ02/17/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2014 Earnings Call for 11-March-2015 9:00 AM ET",FCSTTS02/17/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2014 Earnings Release for 10-March-2015 5:00 PM ET",FCSTTS02/17/15,Supernus to Host Fourth Quarter and Full Year 2014 Earnings Conference Call,PMZ02/11/15,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Cowen & Co. Health Care Conference for 4-March-2015 8:40 AM ET",FCSTEV01/21/15,Supernus Sues TWi for Infringement of Oxtellar XR(R) Patents,PMZ01/16/15,Supernus Sues Par for Infringement of Trokendi XR(R) Patents,PMZ12/10/14,Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR(R),PMZ12/09/14,Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R),PMZ11/24/14,Supernus Announces Issuance of Fifth U.S. Patent Protecting Trokendi XR(R),PMZ11/21/14,Supernus Sues Zydus for Infringement of Trokendi XR(R) Patents,PMZ11/11/14,Supernus Announces Third Quarter 2014 Results,PMZ11/07/14,Supernus Announces Issuance of Fourth U.S. Patent Protecting Trokendi XR(R),PMZ11/04/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Stifel Healthcare Conference for 18-November-2014 10:55 AM ET",FCSTEV11/04/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Piper Jaffray Healthcare Conference for 3-December-2014 2:30 PM ET",FCSTEV11/04/14,Supernus to Present at Two Investor Conferences,PMZ10/29/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2014 Earnings Call for 12-November-2014 9:00 AM ET",FCSTEV10/29/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2014 Earnings Release for 11-November-2014",FCSTEV10/29/14,Supernus to Host Third Quarter 2014 Earnings Conference Call,PMZ10/14/14,Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R),PMZ10/02/14,Supernus Sues Actavis for Infringement of Trokendi XR(R) Patents,PMZ09/22/14,Supernus Provides Business Update,PMZ09/04/14,Supernus Announces Issuance of Fourth US Patent Protecting Oxtellar XR(R),PMZ08/21/14,Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R),PMZ08/19/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules FBR Inaugural Healthcare Conference for 3-September-2014",FCSTEV08/19/14,Supernus to Attend FBR HealthCare Conference in September,PMZ08/15/14,"Five Star Equities Issues New Research Reports on DNDN, HNSN, SCLN and SUPN",NEWS_ACW08/14/14,Supernus Receives FDA Fast Track Designation for SPN-810,PMZ08/11/14,Supernus Announces Second Quarter 2014 Results,PMZ07/29/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2014 Earnings Release for 11-August-2014 5:00 PM ET",FCSTEV07/29/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2014 Earnings Call for 12-August-2014 9:00 AM ET",FCSTEV07/29/14,Supernus to Host Second Quarter 2014 Earnings Conference Call,PMZ07/08/14,Supernus to Receive $30 Million in Non-Dilutive Royalty Deal,PMZ05/21/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Jefferies Global Health Care Conference for 4-June-2014 11:00 AM ET",FCSTEV05/21/14,Supernus to Present at Jefferies Healthcare Conference in June,PMZ05/20/14,Supernus Receives $2 Million Milestone for United Therapeutics' Launch of Orenitram(TM),PMZ05/12/14,Supernus Announces First Quarter 2014 Results,PMZ04/29/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2014 Earnings Call for 13-May-2014 9:00 AM ET",FCSTEV04/29/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2014 Earnings Release for 12-May-2014 After Market Hours ET",FCSTEV04/29/14,Supernus to Host First Quarter 2014 Earnings Conference Call,PMZ04/09/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Annual General Meeting for 22-May-2014",FCSTEV03/12/14,Supernus Announces Fourth Quarter and Full Year 2013 Results,PMZ03/12/14,Supernus Announces Issuance of Third US Patent Protecting Trokendi XRª,BW02/25/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2013 Earnings Call for 13-March-2014 9:00 AM ET",FCSTEV02/25/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2013 Earnings Release for 12-March-2014 After Market Hours ET",FCSTEV02/25/14,Supernus to Host Fourth Quarter and Full Year 2013 Earnings Conference Call,BW02/20/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Cowen & Co. Healthcare Conference for 3-March-2014 1:30 PM ET",FCSTEV02/20/14,Supernus to Present at Cowen and Company Healthcare Conference in March,BW02/07/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules RBC Capital Markets Global Healthcare Conference for 26-February-2014 9:00 AM ET",FCSTEV02/07/14,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Citi Global Healthcare Conference for 25-February-2014",FCSTEV02/07/14,Supernus at Citibank and RBC Global Healthcare Conferences in February,BW02/03/14,Supernus Announces Publication of Phase III Study (PROSPER) Results on Oxtellar XR¨,BW01/27/14,Supernus Announces Issuance of First Use Patents Protecting SPN-812 as a Novel Non-Stimulant ADHD Product,PMZ01/08/14,"Upcoming Conferences, Share Price Updates, and Leadership Changes - Research Report on Lilly, Allergan, Waters, Novavax, and Supernus Pharmaceuticals",PRN01/07/14,Supernus Announces Issuance of Third US Patent Protecting Oxtellar XR(R),PMZ12/30/13,"Healthcare Companies Report Board Changes, FDA Approvals, and Conference Call Schedules - Research Report on Quest Diagnostics, Supernus Pharma, Puma Biotechnology, Pacira, and ResMed",PRN12/24/13,Supernus Announces Resignation of Board Member,PMZ12/23/13,"Supernus Announces FDA Approval of Its Partner's Product, Orenitram(TM)",PMZ12/12/13,Supernus Posts Exciting Clinical Data Regarding Trokendi XR(TM) and Oxtellar XR(TM) on the Company Website,PMZ11/21/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Piper Jaffray Healthcare Conference for 4-December-2013 3:00 PM ET",FCSTEV11/21/13,Supernus to Present at Piper Jaffray Healthcare Conference in December,PMZ11/19/13,"Healthcare Sector Announced Reforms, Financial Results, Public Offerings, Top Rankings and Positive Data - Research Report on Kindred, Zogenix, Sangamo, PhotoMedex and Supernus Pharmaceuticals",PRN11/12/13,Supernus Pharmaceuticals Reports Third Quarter 2013 Financial Results,PMZ11/11/13,"Upcoming Earnings Schedules, Conferences and Quarterly Financial Results - Research Report on Supernus, Ironwood, Neurocrine Biosciences, PhotoMedex, and Kythera",PRN11/06/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2013 Earnings Release for 12-November-2013 After Market Hours ET",FCSTEV11/06/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2013 Earnings Call for 12-November-2013 5:00 PM ET",FCSTEV11/06/13,Supernus Announces Third Quarter 2013 Earnings Conference Call and Webcast,PMZ11/06/13,Supernus Announces Release of Exciting New Clinical Data on Trokendi XR(TM),PMZ09/05/13,Supernus Launches Trokendi XR(TM) in the United States,PMZ08/29/13,Supernus to Present at Two Investor Conferences in September,PMZ08/19/13,Supernus Announces Final FDA Approval and Upcoming Launch of Trokendi XR(TM),PMZ08/14/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Rodman & Renshaw Global Investment Conference for 9-September-2013 11:40 AM ET",FCSTEV08/13/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2013 Earnings Call for 13-August-2013 5:00 PM ET",FCSTEV08/13/13,Supernus Pharmaceuticals Reports Second Quarter 2013 Financial Results,PMZ08/07/13,Supernus Sues Watson for Infringement of Oxtellar XR(TM) Patents,PMZ08/06/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2013 Earnings Release for 13-August-2013 After Market Hours ET",FCSTEV08/06/13,Supernus Announces Second Quarter 2013 Earnings Conference Call and Webcast,PMZ06/27/13,Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR(TM),PMZ06/10/13,Supernus Receives Tentative Approval for Trokendi XR(TM),PMZ05/20/13,Supernus to Present at Two Investor Conferences,PMZ05/13/13,Supernus Pharmaceuticals Reports First Quarter 2013 Financial Results,PMZ05/06/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2013 Earnings Call for 13-May-2013 5:00 PM ET",FCSTEV05/06/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2013 Earnings Release for 13-May-2013 After Market Hours ET",FCSTEV05/06/13,Supernus Announces First Quarter 2013 Earnings Conference Call and Webcast,PMZ05/06/13,Supernus Announces Closing of $90 Million of 7.50% Convertible Senior Secured Notes Due 2019,PMZ04/26/13,Supernus Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019,PMZ04/24/13,Supernus Announces Proposed Offering of $75 Million of Convertible Senior Secured Notes,PMZ03/19/13,"Free Research Reports on CIM, JVA, MS and SUPN Issued by the Bedford Report",INW03/19/13,U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous,INW03/14/13,Supernus Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Financial Results,PMZ03/07/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2012 Earnings Call for 14-March-2013 5:00 PM ET",FCSTEV03/07/13,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q4 2012 Earnings Release for 14-March-2013 After Market Hours ET",FCSTEV03/07/13,Supernus Announces Year-End and Fourth Quarter 2012 Earnings Conference Call and Webcast,PMZ02/01/13,Supernus Launches Oxtellar XR(TM) in the United States,PMZ01/14/13,Supernus Appoints Victor Vaughn as Senior Vice President of Sales,PMZ12/19/12,"Perfect Trade Setups, How to Play SUPN, MLNX, WIN and MDLZ ",INW12/18/12,"The Real Story Behind SUPN, MLNX, WIN and MDLZ ",INW12/03/12,"Free Research Reports on CBK, RIC, SUPN and NTLS Issued by the Bedford Report ",INW11/29/12,Supernus Announces Pricing of Public Offering,PMZ11/20/12,Supernus Announces Positive Phase IIb Results on SPN-810 and Decision to Advance to Late Stage Development,PMZ11/19/12,Supernus Receives Three Years of Market Exclusivity for Oxtellar XR(TM),PMZ11/12/12,Semi-Annual Changes to the NASDAQ Biotechnology Index,PMZ11/07/12,Supernus Pharmaceuticals Reports Third Quarter 2012 Financial Results,PMZ11/06/12,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q3 2012 Earnings Release for 7-November-2012",FCSTEV11/05/12,Supernus Announces Issuance of Two Patents Covering Trokendi XR(TM),PMZ10/31/12,Supernus Announces Resignation of Board Member,PMZ10/22/12,Supernus Receives FDA Approval for Oxtellar XR(TM) in Epilepsy,PMZ08/29/12,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Rodman and Renshaw Global Investment Conference for 10-September-2012 3:40 PM ET",FCSTEV08/29/12,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Stifel Nicolaus Healthcare Conference for 6-September-2012 8:00 AM ET",FCSTEV08/29/12,Supernus to Present at Two Investor Conferences in September 2012,PMZ08/10/12,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q2 2012 Earnings Release for 10-August-2012",FCSTEV08/10/12,Supernus Pharmaceuticals Reports Second Quarter 2012 Financial Results,PMZ07/20/12,"Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer",PMZ07/13/12,Supernus Provides Update on the Launch of Its Two Epilepsy Products Trokendi XR(TM) and SPN-804,PMZ06/26/12,"SmallCapReview.com - Small Cap Biotechs To Watch - SUPN, PBTH, CTIX",NEWS_ACW06/26/12,Supernus Receives Tentative Approval of Trokendi XR(TM) From FDA,PMZ06/07/12,Supernus Pharmaceuticals Reports First Quarter 2012 Financial Results,PMZ06/06/12,"Supernus Pharmaceuticals, Inc.(SUPN-US) Schedules Q1 2012 Earnings Release for 7-June-2012",FCSTEV06/06/12,"Research and Markets: Childhood Epilepsy Therapeutics Market is Forecast To Register Slow Growth at a Compound Annual Growth Rate (CAGR) Of 5.0% to Reach $1,065m By 2019",BW05/04/12,"Supernus Pharmaceuticals, Inc. Announces Closing of Initial Public Offering",PMZ04/30/12,"Supernus Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering",PMZ01/06/12,Supernus Pharmaceuticals Raises $42 Million to Prepare for Launch of Product Candidates in Epilepsy and Develop Pipeline in ADHD,BW11/28/11,Supernus Pharmaceuticals Initiates Phase IIb Clinical Trial for SPN-810 in Impulsive Aggression,BW03/11/11,Supernus Pharmaceuticals Announces Positive Results from Phase IIa Clinical Trial for SPN-812 in Adults with ADHD,BW01/11/11,"Pharma, Biotech Licensing Alliances, Best Practices and Deals to Be Reviewed at Upcoming iiBIG San Diego Summit ",INW07/13/10,Supernus Pharmaceuticals Advances SPN812 into Phase IIa U.S. Clinical Trial for ADHD,BW01/27/10,Supernus Announces Positive Results from Phase IIa Clinical Trial for SPN 810 in Children with ADHD and Serious Conduct Problems,BW